Boston Scientific Acquires Penumbra, Expanding Neurovascular Portfolio – Merger Arbitrage Mondays
Penumbra, Inc. (PEN): $350.78 Market Cap: $13.74B Deal Size: $14.5B Boston Scientific (BSX) entered a merger agreement on January 15, 2026, to acquire medtech firm Penumbra in a…
Written byAsif SuriaSource: InsideArbitrage
Penumbra, Inc. (PEN): $350.78 Market Cap: $13.74B Deal Size: $14.5B Boston Scientific (BSX) entered a merger agreement on January 15, 2026, to acquire medtech firm Penumbra in a deal valued at $14.5 billion to expand its presence in the treatment of blood clots and strokes. The deal is Boston Scientific’s biggest acquisition in the past